CY1108454T1 - Ενωσεις σπειροπυραζολιου - Google Patents

Ενωσεις σπειροπυραζολιου

Info

Publication number
CY1108454T1
CY1108454T1 CY20081101206T CY081101206T CY1108454T1 CY 1108454 T1 CY1108454 T1 CY 1108454T1 CY 20081101206 T CY20081101206 T CY 20081101206T CY 081101206 T CY081101206 T CY 081101206T CY 1108454 T1 CY1108454 T1 CY 1108454T1
Authority
CY
Cyprus
Prior art keywords
spiroprazole
compounds
compound
formula
spiroprazole compounds
Prior art date
Application number
CY20081101206T
Other languages
English (en)
Inventor
R Richard Goehring
Donald Kyle
Gary Lee
Parviz Gharagozloo
Sam Victory
Original Assignee
Euro-Celtique S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro-Celtique S.A. filed Critical Euro-Celtique S.A.
Publication of CY1108454T1 publication Critical patent/CY1108454T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Dental Preparations (AREA)

Abstract

Μια ένωση του Τύπου (Ι) όπου τα Z, W, A, B, C, R1, R2, Q και n είναι όπως περιγράφονται στο παρόν έγγραφο.
CY20081101206T 2001-04-18 2008-10-27 Ενωσεις σπειροπυραζολιου CY1108454T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28467501P 2001-04-18 2001-04-18
EP02739163A EP1385515B1 (en) 2001-04-18 2002-04-18 Spiropyrazole compounds

Publications (1)

Publication Number Publication Date
CY1108454T1 true CY1108454T1 (el) 2014-04-09

Family

ID=23091099

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081101206T CY1108454T1 (el) 2001-04-18 2008-10-27 Ενωσεις σπειροπυραζολιου

Country Status (28)

Country Link
US (2) US6635653B2 (el)
EP (1) EP1385515B1 (el)
JP (1) JP4342181B2 (el)
KR (1) KR100628292B1 (el)
CN (1) CN1516584A (el)
AT (1) ATE403429T1 (el)
AU (1) AU2002311833B2 (el)
BR (1) BR0209127A (el)
CA (1) CA2444634C (el)
CY (1) CY1108454T1 (el)
CZ (1) CZ20032849A3 (el)
DE (1) DE60228071D1 (el)
DK (1) DK1385515T3 (el)
ES (1) ES2312584T3 (el)
HK (1) HK1062885A1 (el)
HU (1) HUP0401333A3 (el)
IL (2) IL158485A0 (el)
MX (1) MXPA03009604A (el)
NO (1) NO20034660L (el)
NZ (1) NZ528978A (el)
PL (1) PL367263A1 (el)
PT (1) PT1385515E (el)
RU (1) RU2299883C2 (el)
SI (1) SI1385515T1 (el)
UA (1) UA74439C2 (el)
WO (1) WO2002085355A1 (el)
YU (1) YU82403A (el)
ZA (1) ZA200308103B (el)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0401333A3 (en) * 2001-04-18 2004-11-29 Euro Celtique Sa Spiropyrazole compounds and pharmaceutical compositions containing them
EP1491212B1 (en) 2002-03-29 2012-08-08 Mitsubishi Tanabe Pharma Corporation Remedy for sleep disturbance
RS20050208A (en) 2002-09-09 2007-08-03 Janssen Pharmaceutica N.V., Hydroxy alkyl substituted 1,3,8- triazaspiro/4,5/decan-4- one derivatives useful for the treatment of orl-1 receptor mediated disorders
MXPA05003881A (es) * 2002-10-17 2005-10-05 Euro Celtique Sa Preparacion de compuestos triazospiro.
US20040242583A1 (en) * 2003-01-20 2004-12-02 Aventis Pharma Deutschland Gmbh Pyrimido[5,4-e][1,2,4]triazine-5,7-diones, processes for preparing them and their use
WO2004103305A2 (en) * 2003-05-16 2004-12-02 Euroceltique S.A. Spiropyrazole compound
WO2005011665A1 (en) * 2003-07-22 2005-02-10 Arakis Ltd. The use of proglumide for the treatment of emesis
US20100009928A1 (en) 2004-03-29 2010-01-14 Cheng Jin Q Compositions including triciribine and taxanes and methods of use thereof
US20110008327A1 (en) * 2004-03-29 2011-01-13 Cheng Jin Q Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof
US20100028339A1 (en) 2004-03-29 2010-02-04 Cheng Jin Q Compositions including triciribine and trastuzumab and methods of use thereof
WO2005094322A2 (en) 2004-03-29 2005-10-13 University Of South Florida Effective treatment of tumors and cancer with triciribine and related compounds
US20100173864A1 (en) * 2004-03-29 2010-07-08 Cheng Jin Q Compositions including triciribine and one or more platinum compounds and methods of use thereof
US20100009929A1 (en) 2004-03-29 2010-01-14 Cheng Jin Q Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof
KR101388453B1 (ko) 2005-03-08 2014-04-23 얀센 파마슈티카 엔.브이. 뉴로키닌 (ｎｋ１) 길항제로서의디아자-스피로-[４.４]-노난 유도체
CN1870631B (zh) * 2005-11-11 2010-04-14 华为技术有限公司 媒体网关的门控方法
US20080051380A1 (en) 2006-08-25 2008-02-28 Auerbach Alan H Methods and compositions for treating cancer
EP2102206B1 (en) 2006-11-28 2015-04-08 Janssen Pharmaceutica NV Salts of 3-(3-amino-2-(r)-hydroxy-propyl)-1-(4-fluoro-phenyl)-8-(8-methyl-naphthalen-1-ylmethyl)-1,3,8-triaza-spiro[4.5]decan-4-one
PT2076506E (pt) 2007-01-16 2010-12-10 Purdue Pharma Lp Compostos de piperidina substituídos nos grupos heterocíclicos como ligandos orl-1
CA2683598C (en) 2007-04-09 2015-11-17 Janssen Pharmaceutica Nv 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the orl-i receptor for the treatment of anxiety and depression
RU2488585C2 (ru) 2007-08-31 2013-07-27 Пэдью Фарма Л.П. Замещенные пиперидиновые соединения хиноксалинового типа и их применение
MY153948A (en) 2008-07-21 2015-04-15 Purdue Pharma Lp Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
UA107943C2 (en) * 2009-11-16 2015-03-10 Lilly Co Eli Compounds of spiropiperidines as antagonists of the orl-1 receptors
WO2012085648A1 (en) 2010-12-22 2012-06-28 Purdue Pharma L.P. Phosphorus-substituted quinoxaline-type piperidine compounds and uses thereof
ES2583146T3 (es) 2011-12-01 2016-09-19 Purdue Pharma L.P. Compuestos de piperidina de tipo quinoxalina sustituidos con azetidina y usos de éstos
US9085561B2 (en) 2012-07-30 2015-07-21 Purdue Pharma L.P. Cyclic urea- or lactam-substituted quinoxaline-type piperidines as ORL-1 modulators
WO2014102588A2 (en) 2012-12-27 2014-07-03 Purdue Pharma L.P. Indole and indoline-type piperidine compounds and uses thereof
WO2014102589A1 (en) 2012-12-27 2014-07-03 Purdue Pharma L.P. Quinazolin-4(3h)-one-type piperidine compounds and uses thereof
US10118927B2 (en) 2012-12-27 2018-11-06 Purdue Pharma L.P. Substituted piperidin-4-amino-type compounds and uses thereof
WO2014102594A2 (en) 2012-12-27 2014-07-03 Purdue Pharma L.P. Substituted benzimidazole-type piperidine compounds and uses thereof
WO2014102592A2 (en) 2012-12-27 2014-07-03 Purdue Pharma L.P. Oxime/substituted quinoxaline-type piperidine compounds and uses thereof
CA3031705A1 (en) 2016-07-29 2018-02-01 Janssen Pharmaceutica Nv Treatment of prostate cancer with niraparib
CN111825681A (zh) * 2020-07-07 2020-10-27 扬州大学 一种合成(e)-亚苄基螺吡唑吡咯嗪酮类化合物的方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB157497A (el) *
US3161645A (en) 1962-12-18 1964-12-15 Res Lab Dr C Janssen N V 1-(1-aroylpropyl-4-piperidyl)-2-benzimidazolinones and related compounds
US3318900A (en) 1964-05-06 1967-05-09 Janssen Pharmaceutica Nv Derivatives of benzimidazolinyl piperidine
US3325499A (en) 1964-11-02 1967-06-13 Mcneilab Inc 1-(1-hydrocarbyl-4-piperdyl)-2-indolinone
US3923993A (en) * 1973-06-28 1975-12-02 American Home Prod Process for treating neuroendocrinopathic diseases employing fluspirilene
DE2609645A1 (de) 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen
US4329353A (en) 1980-10-22 1982-05-11 Janssen Pharmaceutica, N.V. 1-(4-Aryl-cyclohexyl)piperidine derivatives, method of use thereof and pharmaceutical compositions thereof
US4410528A (en) 1980-05-16 1983-10-18 Kyowa Hakko Kogyo Co., Ltd. Hypotensive piperidine derivatives
JPS58180481A (ja) 1982-04-15 1983-10-21 Kyowa Hakko Kogyo Co Ltd 新規なピペリジン誘導体
JPS60120872A (ja) 1983-12-01 1985-06-28 Kyowa Hakko Kogyo Co Ltd 新規なヘテロ環状化合物及び強心剤
CA2187767A1 (en) 1994-04-14 1995-10-26 Joel R. Huff Alpha1c adrenergic receptor antagonists
FR2722190B1 (fr) 1994-07-05 1996-10-04 Sanofi Sa Derives de 1-benzyl-1,3-dihydro-2h-benzimidazol-2-one, leur preparation, les compositions pharmaceutique en contenant
US5767118A (en) 1994-10-26 1998-06-16 Merck & Co., Inc. 4-Heterocyclic peperidines promote release of growth hormone
US5574044A (en) 1994-10-27 1996-11-12 Merck & Co., Inc. Muscarine antagonists
DE69621469T2 (de) 1995-09-13 2002-12-12 Kyowa Hakko Kogyo Co., Ltd. Phenylpiperidin-derivate
US6180649B1 (en) 1996-04-19 2001-01-30 Nerosearch A/S 1-(4-piperidyl)-benzimidazoles having neurotrophic activity
US6063796A (en) 1997-04-04 2000-05-16 Merck & Co., Inc. Somatostatin agonists
JP4366532B2 (ja) 1997-05-30 2009-11-18 萬有製薬株式会社 ２−オキソイミダゾール誘導体
JPH10330377A (ja) 1997-06-02 1998-12-15 Kyowa Hakko Kogyo Co Ltd ピペリジン誘導体
US6166037A (en) 1997-08-28 2000-12-26 Merck & Co., Inc. Pyrrolidine and piperidine modulators of chemokine receptor activity
EP0921125B1 (en) 1997-12-05 2002-01-30 F. Hoffmann-La Roche Ag 1,3,8-Triazaspiro[4,5]decan-4-on derivatives
US6166209A (en) 1997-12-11 2000-12-26 Hoffmann-La Roche Inc. Piperidine derivatives
PL342046A1 (en) 1998-01-19 2001-05-21 Pfizer 4-(2-keto-1-benzimidazolinyl)piperidine compounds as agonists of orl1 receptor
RU2202344C2 (ru) 1998-03-26 2003-04-20 Джапан Тобакко Инк. Антагонисты ноцицептина, производные амида, аналгетик, способ инициирования антагонистического действия к ноцицептину, способ лечения боли, фармацевтические композиции
WO1999059997A1 (en) 1998-05-18 1999-11-25 Novo Nordisk A/S Novel 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes
US6262066B1 (en) 1998-07-27 2001-07-17 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
ID29137A (id) 1998-07-27 2001-08-02 Schering Corp Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1
MA26659A1 (fr) 1998-08-06 2004-12-20 Pfizer Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation.
SE9904652D0 (sv) 1999-12-17 1999-12-17 Astra Pharma Prod Novel Compounds
ATE413878T1 (de) 2000-09-06 2008-11-15 Ortho Mcneil Pharm Inc Methode zum bekämpfen der allergien durch verwendung von substituierten pyrazolen
HUP0401333A3 (en) * 2001-04-18 2004-11-29 Euro Celtique Sa Spiropyrazole compounds and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
WO2002085355A1 (en) 2002-10-31
SI1385515T1 (sl) 2008-12-31
HK1062885A1 (en) 2004-12-03
KR20040008159A (ko) 2004-01-28
PT1385515E (pt) 2008-09-15
ZA200308103B (en) 2004-10-18
DK1385515T3 (da) 2008-10-27
CZ20032849A3 (en) 2004-03-17
RU2003133455A (ru) 2005-05-10
CN1516584A (zh) 2004-07-28
CA2444634C (en) 2011-06-07
DE60228071D1 (de) 2008-09-18
CA2444634A1 (en) 2002-10-31
YU82403A (sh) 2006-08-17
NO20034660L (no) 2003-12-17
IL158485A0 (en) 2004-05-12
ATE403429T1 (de) 2008-08-15
JP2004531531A (ja) 2004-10-14
EP1385515A4 (en) 2004-06-30
IL158485A (en) 2009-09-01
EP1385515B1 (en) 2008-08-06
US20040087641A1 (en) 2004-05-06
UA74439C2 (uk) 2005-12-15
BR0209127A (pt) 2006-03-21
NO20034660D0 (no) 2003-10-17
HUP0401333A2 (hu) 2004-10-28
NZ528978A (en) 2004-06-25
US20030027834A1 (en) 2003-02-06
JP4342181B2 (ja) 2009-10-14
KR100628292B1 (ko) 2006-09-27
MXPA03009604A (es) 2004-04-02
ES2312584T3 (es) 2009-03-01
EP1385515A1 (en) 2004-02-04
US6635653B2 (en) 2003-10-21
AU2002311833B2 (en) 2005-04-28
PL367263A1 (en) 2005-02-21
RU2299883C2 (ru) 2007-05-27
HUP0401333A3 (en) 2004-11-29

Similar Documents

Publication Publication Date Title
CY1108454T1 (el) Ενωσεις σπειροπυραζολιου
CY1108456T1 (el) Ενωσεις βενζιμιδαζολονης
CY1108707T1 (el) Αναλογα νοσισεπτινης
DK1385514T3 (da) Spiroinden- og spiroindanforbindelser
CY1109886T1 (el) Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
NO20041493L (no) Kjemiske forbindelser.
CY1108254T1 (el) Ενωσεις που επηρεαζουν τη γλυκοκιναση
CY1105797T1 (el) Ν-αρυλ-2-οχαζολιδινονο-5-καρβοξαμιδια και παραγωγα αυτων και χρηση αυτων σαν αντιβιοτικα
ATE338461T1 (de) Pyrazolpyrimidinfungizide
SE0004245D0 (sv) Novel compounds and their use
ATE511352T1 (de) Antimikrobielle zusammensetzungen
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
MXPA03009602A (es) Analogos de nociceptina.
SV2003000981A (es) Fenil-heterociclil-eteres ref. pcs10973
ATE431328T1 (de) Photopolymerisierbare verbindungen
EA200600608A1 (ru) Производные имидазопиридина как ингибиторы индуцируемой no-синтазы
RS20050026A (en) Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them
DE69915688D1 (de) Benzonaphtyridin-1,8 derivate